Advertisement

 

 

Radiotherapy in prostate cancer treatment: results of the patterns of care study in Korea.

Radiotherapy in prostate cancer treatment: results of the patterns of care study in Korea.
Author Information (click to view)

Chang AR, Park W,


Chang AR, Park W, (click to view)

Chang AR, Park W,

Advertisement
Share on FacebookTweet about this on TwitterShare on LinkedIn

Radiation oncology journal 2017 03 17() doi 10.3857/roj.2016.01984
Abstract
Purpose
The purpose of this study was to describe treatment patterns of radiotherapy (RT) for prostate cancer in Korea.

Materials and Methods
A questionnaire about radiation treatment technique and principles in 2013 was sent to 83 radiation oncologists and data from 57 hospitals were collected analyzed to find patterns of RT for prostate cancer patients in Korea.

Results
The number of patients with prostate cancer treated with definitive RT ranged from 1 to 72 per hospital in 2013. RT doses and target volumes increased according to risk groups but the range of radiation doses was wide (60 to 81.4 Gy) and the fraction size was diverse (1.8 to 5 Gy). Intensity-modulated radiation therapy was used for definitive treatment in 93.8% of hospitals. Hormonal therapy was integrated with radiation for intermediate (63.2%) and high risk patients (77.2%). Adjuvant RT after radical prostatectomy was performed in 46 hospitals (80.7%). Indications of adjuvant RT included positive resection margin, seminal vesicle invasion, and capsular invasion. The total dose for adjuvant RT ranged from 50 to 72 Gy in 24-39 fractions. Salvage RT was delivered with findings of consecutive elevations in prostate-specific antigen (PSA), PSA level over 0.2 ng/mL, or clinical recurrence. The total radiation doses ranged from 50 to 80 Gy with a range of 1.8 to 2.5 Gy per fraction for salvage RT.

Conclusion
This nationwide patterns of care study suggests that variable radiation techniques and a diverse range of dose fractionation schemes are applied for prostate cancer treatment in Korea. Standard guidelines for RT in prostate cancer need to be developed.

Submit a Comment

Your email address will not be published. Required fields are marked *

4 + three =

[ HIDE/SHOW ]